1. UK Renal Registry 16th Annual Report Figure 13.1. Median height z-scores for transplant patients <16 years in 2012

2. UK Renal Registry 16th Annual Report Figure 13.2. Median weight z-scores for transplant patients <16 years in 2012

3. UK Renal Registry 16th Annual Report Figure 13.3. Median BMI z-scores for transplant patients <16 years in 2012

4. UK Renal Registry 16th Annual Report Figure 13.4. Median height z-scores for dialysis patients <16 years in 2012

5. UK Renal Registry 16th Annual Report Figure 13.5. Median weight z-scores for dialysis patients <16 years in 2012

6. UK Renal Registry 16th Annual Report Figure 13.6. Median BMI z-scores for dialysis patients <16 years in 2012

7. UK Renal Registry 16th Annual Report Figure 13.7. BMI categorisation in children <16 years by modality in 2012

8. UK Renal Registry 16th Annual Report Figure 13.8. Use of growth hormone in children <16 years with a height under 2SD in the UK between 2001 and 2012

9. UK Renal Registry 16th Annual Report Figure 13.9. Median systolic blood pressure z-scores for transplant patients <16 years in 2012

10. UK Renal Registry 16th Annual Report Figure 13.10. Median systolic blood pressure z-scores for dialysis patients <16 years in 2012

11. UK Renal Registry 16th Annual Report Figure 13.11. The percentage of patients <16 years achieving the treatment standard for haemoglobin between 2001–2012, by treatment modality

12. UK Renal Registry 16th Annual Report Figure 13.12. The achievement of haemoglobin treatment standards in paediatric transplant patients <16 years, by the level of graft function This figures combines all data from 2001–2012.

13. UK Renal Registry 16th Annual Report Figure 13.13. The achievement of haemoglobin treatment standards in paediatric transplant patients <16 years, by use of MMF between 2001–2012

14. UK Renal Registry 16th Annual Report Figure 13.14. The use of erythropoietin and IV iron in paediatric patients <16 years between 2001 and 2012 by treatment modality